相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics
Dapeng Zhou et al.
GLYCOBIOLOGY (2021)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
Chunyan Yi et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe et al.
SCIENCE (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread
Adam Brufsky
JOURNAL OF MEDICAL VIROLOGY (2020)
Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop
Javier A. Jaimes et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Yasunori Watanabe et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC
Praveen Anand et al.
ELIFE (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (vol 181, pg 1004, 2020)
Daniel Wrapp et al.
CELL (2020)
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr et al.
CELL (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Christopher O. Barnes et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
Jiandong Huo et al.
CELL HOST & MICROBE (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Jakob Kreye et al.
CELL (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
Shuo Du et al.
CELL (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models
Wei Li et al.
CELL (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Controlling the SARS-CoV-2 spike glycoprotein conformation
Rory Henderson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
Daming Zhou et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
Antoni G. Wrobel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
Zhe Lv et al.
SCIENCE (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan et al.
SCIENCE (2020)
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine
Darja Kanduc et al.
IMMUNOLOGIC RESEARCH (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Zunlong Ke et al.
NATURE (2020)
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
Sean T. H. Liu et al.
NATURE MEDICINE (2020)
Low genetic diversity may be an Achilles heel of SARS-CoV-2
Jason W. Rausch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici et al.
SCIENCE (2020)
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Leo Hanke et al.
NATURE COMMUNICATIONS (2020)
Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
Antoni G. Wrobel et al.
NATURE COMMUNICATIONS (2020)
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
Nicholas C. Wu et al.
CELL REPORTS (2020)
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
Lorenzo Casalino et al.
ACS CENTRAL SCIENCE (2020)
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Wen Shi Lee et al.
NATURE MICROBIOLOGY (2020)
Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2
A. J. Venkatakrishnan et al.
CELL DEATH DISCOVERY (2020)
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
Tongqing Zhou et al.
CELL HOST & MICROBE (2020)
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Michael Schoof et al.
SCIENCE (2020)
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang et al.
SCIENCE (2020)
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
Tania F. Custodio et al.
NATURE COMMUNICATIONS (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
Nicholas K. Hurlburt et al.
NATURE COMMUNICATIONS (2020)
Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
Haixia Zhou et al.
NATURE COMMUNICATIONS (2019)
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
Kevin O. Saunders
FRONTIERS IN IMMUNOLOGY (2019)
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD
Nianshuang Wang et al.
CELL REPORTS (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Structure of the Lassa virus glycan shield provides a model for immunological resistance
Yasunori Watanabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Engineering multi-specific antibodies against HIV-1
Neal N. Padte et al.
RETROVIROLOGY (2018)
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen
Weston B. Struwe et al.
CELL REPORTS (2018)
Single-Domain Antibodies and Their Formatting to Combat Viral Infections
Dorien De Vlieger et al.
ANTIBODIES (2018)
The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner
Alex L. Lai et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey et al.
NATURE MEDICINE (2017)
Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion
Alexandra C. Walls et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies
Mattia Bonsignori et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
Yuan Yuan et al.
NATURE COMMUNICATIONS (2017)
Data, disease and diplomacy: GISAID's innovative contribution to global health
Stefan Elbe et al.
GLOBAL CHALLENGES (2017)
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
Alexandra C. Walls et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
A Trojan horse bispecific-antibody strategy for broad protection against ebolaviruses
Anna Z. Wec et al.
SCIENCE (2016)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti et al.
SCIENCE (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
Alexandra C. Walls et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Fc receptors in antibody-dependent enhancement of viral infections
Adam Taylor et al.
IMMUNOLOGICAL REVIEWS (2015)
Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites
Yanming An et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy
Jeong Hyun Lee et al.
STRUCTURE (2015)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
HIV broadly neutralizing antibody targets
Constantinos Kurt Wibmer et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Coronaviruses: Important Emerging Human Pathogens
Christopher M. Coleman et al.
JOURNAL OF VIROLOGY (2014)
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface
Jinghe Huang et al.
NATURE (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
Xian-Chun Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
Louise Scharf et al.
CELL REPORTS (2014)
HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
Laurent Verkoczy et al.
PLOS PATHOGENS (2014)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus
Kailang Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
Hugo Mouquet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain
John E. Pak et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum
K. -Y. Hwa et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2008)
Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway
Jianhua Sui et al.
PLOS PATHOGENS (2008)
Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R
William C. Hwang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
Jan ter Meulen et al.
PLOS MEDICINE (2006)
Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody
Ponraj Prabakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
分享论文
